Okada Y, Adachi M, Kokubu F, Takahashi T, Tanabe Y, Maeda M, Tsuji A
Arerugi. 1989 Apr;38(4):334-41.
A sulpyrin inhalation test was given to 13 patients with aspirin-induced asthma (AIA) and 8 patients with non-aspirin-induced asthma (non-AIA) to observe the changes in plasma histamine levels before and after challenges. The respiratory function (FEV1.0) was measured before and after sulpyrin inhalation. A decrease of more than 20% the initial value (basal value) was defined as a positive response. Plasma histamine was determined by high-performance liquid chromatography (HPLC). In 11 patients with AIA, a positive response was observed (SIT positive), with a fall of FEV1.0 to 63.70 +/- 4.87% of the basal value. In 2 patients with AIA and 8 patients with non-AIA, no positive response was observed (SIT negative). In patients with SIT positive, plasma histamine levels increased significantly from 0.61 +/- 0.06 ng/ml before challenges to 1.34 +/- 0.22 ng/ml after challenges (p less than 0.01). No significant changes of plasma histamine occurred in the SIT negative patients. These results suggest that mast cells play some role in the mechanism of the development of aspirin-induced asthma.
对13例阿司匹林诱发哮喘(AIA)患者和8例非阿司匹林诱发哮喘(非AIA)患者进行了舒林酸吸入试验,以观察激发前后血浆组胺水平的变化。在舒林酸吸入前后测量呼吸功能(FEV1.0)。初始值(基础值)下降超过20%被定义为阳性反应。采用高效液相色谱法(HPLC)测定血浆组胺。11例AIA患者观察到阳性反应(SIT阳性),FEV1.0降至基础值的63.70 +/- 4.87%。2例AIA患者和8例非AIA患者未观察到阳性反应(SIT阴性)。在SIT阳性患者中,血浆组胺水平从激发前的0.61 +/- 0.06 ng/ml显著增加至激发后的1.34 +/- 0.22 ng/ml(p < 0.01)。SIT阴性患者血浆组胺无显著变化。这些结果表明,肥大细胞在阿司匹林诱发哮喘的发病机制中起一定作用。